BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9647767)

  • 1. Trimidox-mediated morphological changes during erythroid differentiation is associated with the stimulation of hemoglobin and F-cell production in human K562 cells.
    Iyamu EW; Adunyah SE; Elford HL; Fasold H; Turner EA
    Biochem Biophys Res Commun; 1998 Jun; 247(3):759-64. PubMed ID: 9647767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin.
    Iyamu WE; Adunyah SE; Fasold H; Horiuchi K; Elford HL; Asakura T; Turner EA
    Am J Hematol; 2000 Apr; 63(4):176-83. PubMed ID: 10706760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
    Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS
    Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The ribonucleotide reductase enzyme as a target for enzyme-directed chemotherapy effects of trimidox (3,4,5-trihydroxybenzohydroxamidoxim), a new inhibitor of ribonucleotide reductases].
    Findenig G; Vielnascher E; Göbl R; Fritzer-Szekeres M; Szekeres T
    Wien Klin Wochenschr; 1995; 107(22):694-7. PubMed ID: 8533431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibitory and differentiation effects of chloroquine and its analogue on human leukemic cells potentiate fetal hemoglobin production by targeting the polyamine pathway.
    Iyamu E; Perdew H; Woods G
    Biochem Pharmacol; 2009 Mar; 77(6):1021-8. PubMed ID: 19073155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells.
    Leyden D; Ahmed N; Hassan HT
    Anticancer Res; 2000; 20(1A):133-8. PubMed ID: 10769645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells.
    Mischiati C; Sereni A; Lampronti I; Bianchi N; Borgatti M; Prus E; Fibach E; Gambari R
    Br J Haematol; 2004 Aug; 126(4):612-21. PubMed ID: 15287957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL; Wu RT
    Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
    Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
    Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation.
    Rodrigue CM; Arous N; Bachir D; Smith-Ravin J; Romeo PH; Galacteros F; Garel MC
    Br J Haematol; 2001 May; 113(2):500-7. PubMed ID: 11380423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase.
    Szekeres T; Gharehbaghi K; Fritzer M; Woody M; Srivastava A; van't Riet B; Jayaram HN; Elford HL
    Cancer Chemother Pharmacol; 1994; 34(1):63-6. PubMed ID: 8174204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
    Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T
    Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanadate elevates fetal hemoglobin in human erythroid precursors by inhibiting cell maturation.
    Amoyal I; Prus E; Fibach E
    Exp Biol Med (Maywood); 2007 May; 232(5):654-61. PubMed ID: 17463162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on erythroid differentiation of platinum(II) complexes of synthetic bile acid derivatives.
    Lampronti I; Bianchi N; Zuccato C; Medici A; Bergamini P; Gambari R
    Bioorg Med Chem; 2006 Aug; 14(15):5204-10. PubMed ID: 16709458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells.
    Szekeres T; Fritzer M; Strobl H; Gharehbaghi K; Findenig G; Elford HL; Lhotka C; Schoen HJ; Jayaram HN
    Blood; 1994 Dec; 84(12):4316-21. PubMed ID: 7994048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative effects of hemin and anthracyclines in promoting terminal erythroid maturation in K562 human erythroleukemia cells.
    Tsiftsoglou AS; Wong W; Tsamadou AI; Robinson SH
    Exp Hematol; 1991 Oct; 19(9):928-33. PubMed ID: 1893971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ERK activation in growth and erythroid differentiation of K562 cells.
    Woessmann W; Mivechi NF
    Exp Cell Res; 2001 Apr; 264(2):193-200. PubMed ID: 11262176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.
    Fritzer-Szekeres M; Salamon A; Grusch M; Horvath Z; Höchtl T; Steinbrugger R; Jäger W; Krupitza G; Elford HL; Szekeres T
    Biochem Pharmacol; 2002 Aug; 64(3):481-5. PubMed ID: 12147300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ribonucleotide reductase inhibitor trimidox induces c-myc and apoptosis of human ovarian carcinoma cells.
    Rosenberger G; Fuhrmann G; Grusch M; Fassl S; Elford HL; Smid K; Peters GJ; Szekeres T; Krupitza G
    Life Sci; 2000 Nov; 67(26):3131-42. PubMed ID: 11191620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of nonmyelosuppressive nitrosourea analogues with hydroxyurea in the induction of F-cell production in a human erythroleukemic cell line.
    Iyamu EW; Adunyah SE; Fasold H; Horiuchi K; Baliga S; Ohene-Frempong K; Turner EA; Asakura T
    Exp Hematol; 2003 Jul; 31(7):592-600. PubMed ID: 12842704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.